The biological roots of Tourette disorder occur in the basal ganglia, structures deep in the brain involved in the control of ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients.

Tourette syndrome (TS) is clinically significant because it is much more common than previously thought, is easily misdiagnosed, and is often associated with significant comorbidity ...

Baylen is worried about undergoing a deep brain stimulation procedure to help with her tics Baylen Dupree is saying “hell no” to a potential treatment for her Tourette syndrome. In PEOPLE's ...

BBC producer Isabel Kimbrey was diagnosed with Tourette’s syndrome at the age ... to people - “it’s often seen as the swearing disease or the punchline of the joke… it’s none of those ...

The electrical wrist stimulation is now being trialled in people with Parkinson’s Disease (PD) in a two-year study funded by ...

1 According to the Centers for Disease Control and Prevention (CDC), approximately ... ecopipam can provide symptomatic relief from the tics suffered by patients with Tourette syndrome,” said Eric ...

A new wrist device for Parkinson’s may help reduce tremors. Learn about this breakthrough research. Read more.

The US Centers for Disease Control (CDC ... 44% of those children have been diagnosed with moderate or severe Tourette syndrome, with boys three times more likely to live with the condition ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...